LIGAND PHARMACEUTICALS INCORPORATED Increase (Decrease) in Income Taxes Payable
LIGAND PHARMACEUTICALS INCORPORATED (LGNDZ) reported Increase (Decrease) in Income Taxes Payable of $5.82 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2023-11-09
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in income taxes payable for the quarter ending 2023-09-30 was -$10.18M, a 266.93% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in income taxes payable for the quarter ending 2023-06-30 was $11.39M.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in income taxes payable for the quarter ending 2023-03-31 was $4.61M, a 61.53% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in income taxes payable for the quarter ending 2022-09-30 was $6.10M.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month |
|---|---|---|---|
| 2023-09-30 | -$10.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.20M derived: sum of 2 quarters · filed 2023-11-09 | $5.82M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $11.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $16.00M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $4.61M 10-Q · filed 2023-05-08 | ||
| 2022-09-30 | $6.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $3.12M derived: sum of 2 quarters · filed 2023-11-09 | $15.11M 10-Q · filed 2023-11-09 |
| 2022-06-30 | -$2.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $9.01M 10-Q · filed 2023-08-09 | |
| 2022-03-31 | $11.99M 10-Q · filed 2023-05-08 | ||
| 2021-09-30 | -$1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$5.24M derived: sum of 2 quarters · filed 2022-11-08 | -$4.17M 10-Q · filed 2022-11-08 |
| 2021-06-30 | -$3.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$2.48M 10-Q · filed 2022-08-09 | |
| 2021-03-31 | $1.07M 10-Q · filed 2022-05-09 | ||
| 2020-09-30 | $3.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $7.95M derived: sum of 2 quarters · filed 2021-11-09 | $12.03M 10-Q · filed 2021-11-09 |
| 2020-06-30 | $4.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $8.67M 10-Q · filed 2021-08-03 | |
| 2020-03-31 | $4.08M 10-Q · filed 2021-05-06 | ||
| 2019-09-30 | -$30.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$97.43M derived: sum of 2 quarters · filed 2020-11-06 | $16.57M 10-Q · filed 2020-11-06 |
| 2019-06-30 | -$66.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $47.45M 10-Q · filed 2020-08-07 | |
| 2019-03-31 | $114.00M 10-Q · filed 2020-05-08 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $0.00 derived: sum of 2 quarters · filed 2019-11-08 | $0.00 10-Q · filed 2019-11-08 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 |